Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
The Cancer Letter's weekly podcast of interviews, discussions, and more to dig deep into the issues that shape oncology.
New episodes every Wednesday.
SUBSCRIBE ON
Spotify Apple Podcast YouTube
Spotify Apple Podcast YouTube
on air
Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
Podcast

Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”

December 10, 2025
Roy Herbst remembers the late Edward Chu, “the baritone of reason” and “a gentle giant”
Podcast

Roy Herbst remembers the late Edward Chu, “the baritone of reason” and “a gentle giant”

December 03, 2025
Vol.51 No.43
Oncofertility has been an overlooked standard of care—now states are taking action
Podcast

Oncofertility has been an overlooked standard of care—now states are taking action

November 26, 2025
Ellen Sigal and Karen Knudsen “gush” about new CDER Director Richard Pazdur and his late wife, Mary
Podcast

Ellen Sigal and Karen Knudsen “gush” about new CDER Director Richard Pazdur and his late wife, Mary

November 19, 2025
Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
Podcast

Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership

November 12, 2025
The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
PodcastThe Directors

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.”

November 07, 2025
Vol.51 No.41
By Jacquelyn Cobb and Paul Goldberg
Site visits are gone, but outlook for new, centralized CCSG review is bright
Podcast

Site visits are gone, but outlook for new, centralized CCSG review is bright

November 05, 2025
Early endpoints are a balance of risk and benefit
Podcast

Early endpoints are a balance of risk and benefit

October 29, 2025
Vol.51 No.39
Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer
Podcast

Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer

October 22, 2025
Vol.51 No.38
Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities
Podcast

Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities

October 15, 2025
Vol.51 No.37

Posts navigation

Previous12345…8Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
  • Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
  • One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
  • As more people are surviving cancer, we must continue funding bold science
  • GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
    Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account